A Multimodality Machine Learning Approach to Differentiate Severe and Nonsevere COVID-19: Model Development and Validation
BackgroundEffectively and efficiently diagnosing patients who have COVID-19 with the accurate clinical type of the disease is essential to achieve optimal outcomes for the patients as well as to reduce the risk of overloading the health care system. Currently, severe and nons...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2021-04-01
|
Series: | Journal of Medical Internet Research |
Online Access: | https://www.jmir.org/2021/4/e23948 |
id |
doaj-61d958519ee7459d8a9254712558ea5e |
---|---|
record_format |
Article |
spelling |
doaj-61d958519ee7459d8a9254712558ea5e2021-04-07T13:31:22ZengJMIR PublicationsJournal of Medical Internet Research1438-88712021-04-01234e2394810.2196/23948A Multimodality Machine Learning Approach to Differentiate Severe and Nonsevere COVID-19: Model Development and ValidationChen, YuanfangOuyang, LiuBao, Forrest SLi, QianHan, LeiZhang, HengdongZhu, BaoliGe, YaorongRobinson, PatrickXu, MingLiu, JieChen, Shi BackgroundEffectively and efficiently diagnosing patients who have COVID-19 with the accurate clinical type of the disease is essential to achieve optimal outcomes for the patients as well as to reduce the risk of overloading the health care system. Currently, severe and nonsevere COVID-19 types are differentiated by only a few features, which do not comprehensively characterize the complicated pathological, physiological, and immunological responses to SARS-CoV-2 infection in the different disease types. In addition, these type-defining features may not be readily testable at the time of diagnosis. ObjectiveIn this study, we aimed to use a machine learning approach to understand COVID-19 more comprehensively, accurately differentiate severe and nonsevere COVID-19 clinical types based on multiple medical features, and provide reliable predictions of the clinical type of the disease. MethodsFor this study, we recruited 214 confirmed patients with nonsevere COVID-19 and 148 patients with severe COVID-19. The clinical characteristics (26 features) and laboratory test results (26 features) upon admission were acquired as two input modalities. Exploratory analyses demonstrated that these features differed substantially between two clinical types. Machine learning random forest models based on all the features in each modality as well as on the top 5 features in each modality combined were developed and validated to differentiate COVID-19 clinical types. ResultsUsing clinical and laboratory results independently as input, the random forest models achieved >90% and >95% predictive accuracy, respectively. The importance scores of the input features were further evaluated, and the top 5 features from each modality were identified (age, hypertension, cardiovascular disease, gender, and diabetes for the clinical features modality, and dimerized plasmin fragment D, high sensitivity troponin I, absolute neutrophil count, interleukin 6, and lactate dehydrogenase for the laboratory testing modality, in descending order). Using these top 10 multimodal features as the only input instead of all 52 features combined, the random forest model was able to achieve 97% predictive accuracy. ConclusionsOur findings shed light on how the human body reacts to SARS-CoV-2 infection as a unit and provide insights on effectively evaluating the disease severity of patients with COVID-19 based on more common medical features when gold standard features are not available. We suggest that clinical information can be used as an initial screening tool for self-evaluation and triage, while laboratory test results should be applied when accuracy is the priority.https://www.jmir.org/2021/4/e23948 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Chen, Yuanfang Ouyang, Liu Bao, Forrest S Li, Qian Han, Lei Zhang, Hengdong Zhu, Baoli Ge, Yaorong Robinson, Patrick Xu, Ming Liu, Jie Chen, Shi |
spellingShingle |
Chen, Yuanfang Ouyang, Liu Bao, Forrest S Li, Qian Han, Lei Zhang, Hengdong Zhu, Baoli Ge, Yaorong Robinson, Patrick Xu, Ming Liu, Jie Chen, Shi A Multimodality Machine Learning Approach to Differentiate Severe and Nonsevere COVID-19: Model Development and Validation Journal of Medical Internet Research |
author_facet |
Chen, Yuanfang Ouyang, Liu Bao, Forrest S Li, Qian Han, Lei Zhang, Hengdong Zhu, Baoli Ge, Yaorong Robinson, Patrick Xu, Ming Liu, Jie Chen, Shi |
author_sort |
Chen, Yuanfang |
title |
A Multimodality Machine Learning Approach to Differentiate Severe and Nonsevere COVID-19: Model Development and Validation |
title_short |
A Multimodality Machine Learning Approach to Differentiate Severe and Nonsevere COVID-19: Model Development and Validation |
title_full |
A Multimodality Machine Learning Approach to Differentiate Severe and Nonsevere COVID-19: Model Development and Validation |
title_fullStr |
A Multimodality Machine Learning Approach to Differentiate Severe and Nonsevere COVID-19: Model Development and Validation |
title_full_unstemmed |
A Multimodality Machine Learning Approach to Differentiate Severe and Nonsevere COVID-19: Model Development and Validation |
title_sort |
multimodality machine learning approach to differentiate severe and nonsevere covid-19: model development and validation |
publisher |
JMIR Publications |
series |
Journal of Medical Internet Research |
issn |
1438-8871 |
publishDate |
2021-04-01 |
description |
BackgroundEffectively and efficiently diagnosing patients who have COVID-19 with the accurate clinical type of the disease is essential to achieve optimal outcomes for the patients as well as to reduce the risk of overloading the health care system. Currently, severe and nonsevere COVID-19 types are differentiated by only a few features, which do not comprehensively characterize the complicated pathological, physiological, and immunological responses to SARS-CoV-2 infection in the different disease types. In addition, these type-defining features may not be readily testable at the time of diagnosis.
ObjectiveIn this study, we aimed to use a machine learning approach to understand COVID-19 more comprehensively, accurately differentiate severe and nonsevere COVID-19 clinical types based on multiple medical features, and provide reliable predictions of the clinical type of the disease.
MethodsFor this study, we recruited 214 confirmed patients with nonsevere COVID-19 and 148 patients with severe COVID-19. The clinical characteristics (26 features) and laboratory test results (26 features) upon admission were acquired as two input modalities. Exploratory analyses demonstrated that these features differed substantially between two clinical types. Machine learning random forest models based on all the features in each modality as well as on the top 5 features in each modality combined were developed and validated to differentiate COVID-19 clinical types.
ResultsUsing clinical and laboratory results independently as input, the random forest models achieved >90% and >95% predictive accuracy, respectively. The importance scores of the input features were further evaluated, and the top 5 features from each modality were identified (age, hypertension, cardiovascular disease, gender, and diabetes for the clinical features modality, and dimerized plasmin fragment D, high sensitivity troponin I, absolute neutrophil count, interleukin 6, and lactate dehydrogenase for the laboratory testing modality, in descending order). Using these top 10 multimodal features as the only input instead of all 52 features combined, the random forest model was able to achieve 97% predictive accuracy.
ConclusionsOur findings shed light on how the human body reacts to SARS-CoV-2 infection as a unit and provide insights on effectively evaluating the disease severity of patients with COVID-19 based on more common medical features when gold standard features are not available. We suggest that clinical information can be used as an initial screening tool for self-evaluation and triage, while laboratory test results should be applied when accuracy is the priority. |
url |
https://www.jmir.org/2021/4/e23948 |
work_keys_str_mv |
AT chenyuanfang amultimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT ouyangliu amultimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT baoforrests amultimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT liqian amultimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT hanlei amultimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT zhanghengdong amultimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT zhubaoli amultimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT geyaorong amultimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT robinsonpatrick amultimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT xuming amultimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT liujie amultimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT chenshi amultimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT chenyuanfang multimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT ouyangliu multimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT baoforrests multimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT liqian multimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT hanlei multimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT zhanghengdong multimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT zhubaoli multimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT geyaorong multimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT robinsonpatrick multimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT xuming multimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT liujie multimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation AT chenshi multimodalitymachinelearningapproachtodifferentiatesevereandnonseverecovid19modeldevelopmentandvalidation |
_version_ |
1721535958554247168 |